In: Pediatric Cardiology, 2015, vol. 36, no. 1, p. 96-105
|
In: Interactive CardioVascular and Thoracic Surgery, 2018, vol. 27, no. 2, p. 198-201
|
In: European Archives of Psychiatry and Clinical Neuroscience, 2015, vol. 265, no. 8, p. 637-645
|
In: European Radiology, 2015, vol. 25, no. 7, p. 2067-2073
|
In: Clinical Research in Cardiology, 2015, vol. 104, no. 2, p. 136-144
|
In: Journal of Infectious Diseases, ///-
|
In: Cardiovascular Research, 2016, vol. 109, no. 1, p. 103-114
|
In: European Journal of Applied Physiology, 2015, vol. 115, no. 1, p. 119-128
|
In: American Journal of Hypertension, 2018, vol. 31, no. 2, p. 188-196
|
In: Cardiovascular Revascularization Medicine, 2019, vol. 20, no. 7, p. 577–582
Background: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential improvement in percutaneous coronary intervention (PCI) after the groundbreaking development of drug eluting stents (DES). However, the clinical performance, long-term safety and efficacy of BVS in complex coronary lesions remain uncertain. COMPARE ABSORB, a multicenter, single blind, prospective ...
|